Opinion|Videos|August 22, 2024
Refining Diabetes Care for Older Adults: Expert Insights on Deprescribing, Streamlining Treatment, and Key Practice Pearls
Experts on diabetes provide insights gleaned from the SIMPLE study and outline patient factors that inform treatment decisions.
Advertisement
Episodes in this series
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
CagriSema Cuts Weight Up to 27% Across Menopause Stages: TMS 2026
2
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
3
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
4
Menopause Hormone Therapy Gaps Raise Questions for Primary Care
5